Sign In
News Digest /
Income Statements
Income Statements
11:01am, Wednesday, Aug 06, 2025
Stepan Company (NYSE: SCL) - Q2 2025 Financial Review
In the second quarter of 2025, Stepan Company reported a net income of $11.3 million, translating to $0.50 per diluted share, an increase from the $9.5 million or $0.42 per diluted share reported in Q2 2024. This improvement indicates a strong...
10:06am, Wednesday, Aug 06, 2025
Plumas Bancorp (NASDAQ: PLBC)
Plumas Bancorp has demonstrated a steady performance in its financial results for the first half of 2025, with key developments impacting its overall financial health.
Key Income Statement Highlights:
Net Income: $13.5 million for the six months ended June 30, 2025,...
10:05am, Wednesday, Aug 06, 2025
Charles River Laboratories International, Inc. (NYSE: CRL) has recently reported its financial results for the quarterly period ended June 28, 2025. The company operates in the global drug development sector, providing essential services to pharmaceutical and biotechnology companies.
Key Highligh...
10:04am, Wednesday, Aug 06, 2025
Delcath Systems, Inc. (NASDAQ: DCTH) - Q2 2025 Financial Overview
Delcath Systems, Inc., a biopharmaceutical company and leader in the treatment of cancers affecting the liver, has recently released its financial report for the quarter ending June 30, 2025. The company has shown significant progr...
10:03am, Wednesday, Aug 06, 2025
Global Payments Inc. (NYSE: GPN) has recently released its quarterly earnings report for the period ending June 30, 2025. The company is involved in the payments technology sector and is actively engaged in strategic transitions related to acquisitions and divestitures.
Key Financial Highlights:
...
10:02am, Wednesday, Aug 06, 2025
Company Overview: Verb Technology Company, Inc. (NASDAQ: VERB) primarily focuses on livestream shopping and social commerce. As of June 30, 2025, it has expanded its operations significantly through the acquisition of LyveCom, enhancing its technology and market presence.
Key Income Statement Hig...
10:02am, Wednesday, Aug 06, 2025
Royalty Pharma plc (NASDAQ: RPRX) recently filed its Q2 2025 financial results, revealing a mix of positive outlooks and challenges.
Key Financial Highlights:
Total revenues: $578.7 million, up from $537.3 million year-over-year, a 7.7% increase.
Income from financial royalty assets: $550.4 mill...
10:01am, Wednesday, Aug 06, 2025
Caterpillar Inc. (NYSE: CAT) recently released its quarterly report for the period ended June 30, 2025. Below is an analysis of key findings from the income statement, highlighting both positive and negative aspects of the financial performance.
Positive Aspects:
Total revenues in the second qua...
10:00am, Wednesday, Aug 06, 2025
OPENLANE, Inc. (NYSE: KAR) released its financial results for the second quarter of 2025, indicating both positive and negative trends in its income statement and operational performance.
Key Financial Highlights:
Total Revenue: $481.7 million (up 9% YoY from $443.8 million)
Net Income: $33.4 mi...
09:07am, Wednesday, Aug 06, 2025
Company Overview
Holley Inc. (NYSE: HLLY) designs and manufactures high-performance automotive products, primarily serving car enthusiasts in North America, Canada, and Europe. The company specializes in carburetors, fuel injection systems, and various performance automotive components.
Recent Pe...
09:07am, Wednesday, Aug 06, 2025
Verona Pharma plc (NASDAQ: VRNA) - Company Overview
Verona Pharma is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases with significant unmet medical needs. The company has gained attention recently due to the FDA approval of its first commercial prod...
09:06am, Wednesday, Aug 06, 2025
Paysign, Inc. (NASDAQ: PAYS) has released its quarterly report for the period ending June 30, 2025, showing significant growth in net income and revenues despite challenges in some business segments.
Positive Aspects:
Revenue Growth: Total revenues for Q2 2025 reached $19,078,353, a 33.1% increa...
09:06am, Wednesday, Aug 06, 2025
Conduent Incorporated (NYSE: CNDT) has recently published its Q2 2025 earnings report, highlighting a challenging period for the company amidst significant changes in its strategy and operations.
Key Highlights from the Income Statement:
Revenue: Decreased to $754 million in Q2 2025 from $828 mi...
09:06am, Wednesday, Aug 06, 2025
International Seaways, Inc. (NYSE: INSW) has reported its quarterly financial results for the period ending June 30, 2025, reflecting significant fluctuations in its shipping revenues and overall financial health.
Key Financial Highlights:
Net Income: $61.65 million (Q2 2025), down from $144.72 ...
09:05am, Wednesday, Aug 06, 2025
SmartRent, Inc. (NASDAQ: SMRT)
Q2 2025 Financial Update
SmartRent, Inc., a provider of smart home solutions, reported disappointing financial results for the second quarter and the first half of 2025. The company's revenues decreased substantially, impacting their overall financial stability.
Key...
09:05am, Wednesday, Aug 06, 2025
Company Overview Solo Brands, Inc. (NYSE: DTC) operates premium brands focusing on innovative outdoor products through both direct-to-consumer and retail channels. Recently, the company has been navigating significant operational challenges and restructuring efforts.
Financial Highlights
- Net Sa...
09:04am, Wednesday, Aug 06, 2025
Centuri Holdings, Inc. (NYSE: CTRI)
Centuri Holdings, Inc. is a leading utility infrastructure services company that recently reported its financial results for the fiscal quarter ending June 29, 2025. The earnings reveal a mixed performance, primarily affected by both external market conditions ...
09:04am, Wednesday, Aug 06, 2025
Solitario Resources Corp. (NYSE: XPL) has published its quarterly report for the period ending June 30, 2025. The results reflect various operational and financial undertakings amid ongoing exploration activities for mineral properties.
Key Financial Highlights:
Net Loss: $943,000 for Q2 2025 co...
09:03am, Wednesday, Aug 06, 2025
Southwest Gas Holdings, Inc. (NYSE: SWX) has reported its financial performance for the second quarter of 2025, revealing a mix of positive and negative trends.
Key Highlights:
Revenue: Total operating revenues fell to $1.12 billion in Q2 2025 from $1.18 billion in Q2 2024, primarily due to a de...
09:03am, Wednesday, Aug 06, 2025
Pulmatrix, Inc. (NASDAQ: PULM) is a biopharmaceutical company focused on developing inhaled therapeutic products for migraine and respiratory diseases using its patented iSPERSE™ technology. As of June 30, 2025, the company reported several key financial metrics.
Revenues: No revenue reported fo...
09:02am, Wednesday, Aug 06, 2025
Pinnacle West Capital Corporation (NYSE: PNW) recently released its condensed consolidated financial results for the second quarter of 2025, revealing a mix of positive and negative trends in its income statement. Below are the key financial highlights and implications of their performance.
Incom...
09:01am, Wednesday, Aug 06, 2025
Marriott Vacations Worldwide Corporation (NYSE: VAC) has recently released its quarterly financial results for the period ended June 30, 2025, reflecting a mixed performance with both positive and negative indicators.
Key Financial Highlights:
Total Revenues: Increased by 9% to $1,246 million fr...
09:01am, Wednesday, Aug 06, 2025
Organon & Co. (NYSE: OGN) has reported its financial results for the second quarter ended June 30, 2025, revealing both positive and negative trends in its income statement.
Key Highlights:
Revenues: Declined slightly to $1.594 billion in Q2 2025 from $1.607 billion in Q2 2024.
Gross Profit: Dro...
08:16am, Wednesday, Aug 06, 2025
Shopify Inc. (NYSE: SHOP) Q2 2025 Earnings Summary
As of June 30, 2025, Shopify Inc. reported significant growth amid mixed financial outcomes due to increased operational costs and fluctuating investment returns. Below is a consolidated analysis of the income statement performance:
Revenue Grow...
08:15am, Wednesday, Aug 06, 2025
iTeos Therapeutics, Inc. (NASDAQ: ITOS) has faced significant operational challenges, culminating in the decision to wind down its clinical and operational activities following the termination of its collaboration with GlaxoSmithKline (GSK).
Recent Developments:
As of June 30, 2025, iTeos annou...
08:15am, Wednesday, Aug 06, 2025
The Brink's Company (NYSE: BCO) has released its quarterly results for the period ending June 30, 2025. The company reported a slight increase in revenues alongside mixed results in expenses and profitability metrics.
Positive Aspects:
Revenue Growth: Total revenues for Q2 2025 reached $1,300.5 ...
08:15am, Wednesday, Aug 06, 2025
Q32 Bio Inc. (NASDAQ: QTTB) - Financial Overview and Analysis
Company Overview:
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing innovative biologics to restore healthy immune function in patients suffering from autoimmune and inflammatory diseases. The company's lead ...
08:14am, Wednesday, Aug 06, 2025
Viridian Therapeutics, Inc. (NASDAQ: VRDN) - Q2 2025 Financial Overview
Viridian Therapeutics reported its financial results for the quarter ending June 30, 2025, highlighting both significant operational achievements and challenges. The company's focus lies in developing therapies for rare disea...
08:13am, Wednesday, Aug 06, 2025
Entrada Therapeutics, Inc. (NASDAQ: TRDA)
Entrada Therapeutics is a clinical-stage biopharmaceutical company focusing on the development of a novel class of medicines using their Endosomal Escape Vehicle (EEV™) technology. The company is currently investing heavily in early-stage therapeutic cand...
08:11am, Wednesday, Aug 06, 2025
Lineage, Inc. (NASDAQ: LINE) - Q2 2025 Financial Overview
Company Highlights:
Established as a global leader in temperature-controlled warehousing and logistics, managing about 88 million square feet across 500 warehouses.
Segmented operations into Global Warehousing and Global Integrated Soluti...
08:11am, Wednesday, Aug 06, 2025
Upstream Bio, Inc. (NASDAQ: UPB) - Q2 2025 Analysis
Upstream Bio, Inc. has reported its Q2 2025 financials, revealing a notable expansion in operating expenses amidst continuing development efforts for its clinical-stage product candidate, verekitug.
Key Financial Metrics
Net Loss: $39.97 millio...
08:10am, Wednesday, Aug 06, 2025
MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on developing and commercializing innovative therapeutic products, particularly for endocrine and orphan lung diseases. As of the second quarter of 2025, the company reported a mixed financial performance with both positiv...
08:09am, Wednesday, Aug 06, 2025
Company: Scholar Rock Holding Corporation (NASDAQ: SRRK)
Recent Developments:
In April 2025, David Hallal was appointed CEO following Jay T. Backstrom's transition to Senior Advisor.
Scholar Rock announced positive top-line data from the Phase 2 EMBRAZE trial evaluating apitegromab for preservin...
08:08am, Wednesday, Aug 06, 2025
Dayforce, Inc. (NYSE: CDAY) reported its quarterly results for the period ending June 30, 2025, reflecting both growth and challenges in their financial landscape.
Key Highlights:
**Total Revenue:** Increased to $464.7 million, up 9.8% from $423.3 million in the same period last year.
**Recurrin...
08:08am, Wednesday, Aug 06, 2025
Latham Group, Inc. (NASDAQ: SWIM) reported on its financial performance for the fiscal quarter ending June 28, 2025. This analysis outlines key developments within the company along with notable figures from its income statement.
Positive Aspects:
Net Sales Growth: Net sales increased by 7.8% ye...
08:07am, Wednesday, Aug 06, 2025
Dine Brands Global, Inc. (NYSE: DIN) has released its financial results for the second quarter and first half of 2025, showcasing a blend of both positive and negative indicators regarding its operational performance and financial health.
Key Financial Highlights
Total revenues: Increased to $23...
08:06am, Wednesday, Aug 06, 2025
Vishay Intertechnology, Inc. (NYSE: VSH) has reported its quarterly financial results for the period ending June 28, 2025. The company, known for its wide range of discrete semiconductors and passive electronic components, has experienced both challenges and successes in recent reporting periods....
08:05am, Wednesday, Aug 06, 2025
Arbutus Biopharma Corporation (NASDAQ: ABUS) has reported significant changes in its financial condition for the second quarter and first half of the year 2025. The company operates in the biopharmaceutical sector, focusing on the development of treatments for chronic hepatitis B (cHBV).
Positive...
08:04am, Wednesday, Aug 06, 2025
Company Overview:
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company focused on developing life-changing medicines, particularly in the fields of neuroscience and oncology. The company has recently expanded its product portfolio through the acquisition of Chimerix.
Inco...
08:04am, Wednesday, Aug 06, 2025
Bioventus Inc. (NASDAQ: BVS) - Second Quarter 2025 Overview
Bioventus Inc. has reported its second-quarter results for 2025, revealing both positive movements and challenges in its financial performance. The company specializes in medical devices aimed at addressing musculoskeletal challenges.
Ke...
